PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27199074-6 2016 In addition, E-4031 treatment shifted the steady-state half maximal activation voltage (V1/2 ) of the inactivation curve by +8 mV in cells co-expressing G604S-hERG and WT-hERG. E 4031 13-19 ETS transcription factor ERG Homo sapiens 159-163 27199074-6 2016 In addition, E-4031 treatment shifted the steady-state half maximal activation voltage (V1/2 ) of the inactivation curve by +8 mV in cells co-expressing G604S-hERG and WT-hERG. E 4031 13-19 ETS transcription factor ERG Homo sapiens 171-175 27199074-8 2016 E-4031 treatment resulted in a significant increase in hERG currents by promoting the hERG channel processing and trafficking in cells co-expressing G604S-hERG and WT-hERG. E 4031 0-6 ETS transcription factor ERG Homo sapiens 55-59 27199074-8 2016 E-4031 treatment resulted in a significant increase in hERG currents by promoting the hERG channel processing and trafficking in cells co-expressing G604S-hERG and WT-hERG. E 4031 0-6 ETS transcription factor ERG Homo sapiens 86-90 27199074-8 2016 E-4031 treatment resulted in a significant increase in hERG currents by promoting the hERG channel processing and trafficking in cells co-expressing G604S-hERG and WT-hERG. E 4031 0-6 ETS transcription factor ERG Homo sapiens 86-90 27199074-8 2016 E-4031 treatment resulted in a significant increase in hERG currents by promoting the hERG channel processing and trafficking in cells co-expressing G604S-hERG and WT-hERG. E 4031 0-6 ETS transcription factor ERG Homo sapiens 86-90